Combination drug treatment of beingn prostatic hyperplasia (BPH
dc.contributor.author | Oliech, JS | |
dc.date.accessioned | 2013-04-22T12:55:54Z | |
dc.date.available | 2013-04-22T12:55:54Z | |
dc.date.issued | 2010 | |
dc.identifier.citation | The Annals of African Surgery, (2010) | en |
dc.identifier.uri | http://erepository.uonbi.ac.ke:8080/xmlui/handle/123456789/16498 | |
dc.description.abstract | Combination use of alpha-adrenergic blockers (tamsulocin or alfuzocin) and 5 alpha iso-enzyme 1&2 inhibitor (dutasteride) in symptomatic benign prostatic hyperplasia (BPH) is the best first optional mode of treatment giving good results with minimal treatment adverse effects especially for those at risk for surgical intervention and those who are still sexually active. | en |
dc.language.iso | en | en |
dc.title | Combination drug treatment of beingn prostatic hyperplasia (BPH | en |
dc.type | Article | en |
local.publisher | Department of Surgery | en |
Files in this item
This item appears in the following Collection(s)
-
Faculty of Health Sciences (FHS) [10387]